Current therapies for asthma and allergy are relatively safe and effective at controlling
symptoms but do not change the chronic course of disease. There is no established method …

Nanotechnology-based strategies can dramatically impact the treatment, prevention and
diagnosis of a wide range of diseases. Despite the unprecedented success achieved with …

Allergen-specific immunotherapy (AIT) has been used for more than 100 years as a
tolerance-inducing therapy for allergic diseases and represents a potentially curative …

Sensitization to cat is a common cause of allergic disease all over the world. Symptoms
range from mild rhinoconjunctivitis to potentially life-threatening asthmatic exacerbations. In …

Allergen-specific immunotherapy (SIT) is the only available curative treatment of allergic
diseases. Recent evidence provided a plausible explanation to its multiple mechanisms …

The number of patients suffering from allergic asthma and rhinoconjunctivitis has increased
dramatically within the last decades. Allergen‐specific immunotherapy (AIT) is the only …

Allergen-specific sublingual immunotherapy (SLIT), a safe and efficient route for treating
type I hypersensitivity disorders, requires high doses of allergens. SLIT is generally …

IgE‐mediated allergies, in particular allergic rhinoconjunctivitis and asthma, have reached
epidemic proportions, affecting about one‐third of the population in developed countries …

An immune response to an antigen is more efficiently induced in combination with an
adjuvant. Chitosan has due to documented immunostimulatory characteristics been …

Furry animals cause respiratory allergies in a significant proportion of the population. A
majority of all mammalian allergens are spread as airborne particles, and several have been …